Regulatory mechanism of electroacupuncture in irritable bowel syndrome: Preventing MC activation and decreasing SP VIP secretion

Digestive Diseases and Sciences

Volumn 53, Issue 6, 2008, Pages 1644-1651

  Wu, Huan Gan ^a   Jiang, Bin ^a   Zhou, En Hua ^a   Shi, Zheng ^a   Shi, Da Ren ^b   Cui, Yun Hua ^a   Kou, Suo Tang ^a   Liu, Hui Rong ^a  

^a SHANGHAI RESEARCH INSTITUTE OF ACUPUNCTURE AND MERIDIAN   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Electroacupuncture therapy; Irritable bowel disease; Mucosal mast cell; Regulatory mechanism; Substance P Vasoactive intestinal polypeptide

Indexed keywords

EOSIN; HEMATOXYLIN; PROTEIN C FOS; SEROTONIN AGONIST; ST 25; SUBSTANCE P; SUBSTANCE P RECEPTOR; TEGASEROD; TOLONIUM CHLORIDE; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ABDOMINAL REFLEX; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL COUNT; CELL PROLIFERATION; COLON DILATATION; COLON MUCOSA; CONTROLLED STUDY; ELECTROACUPUNCTURE; IMMUNOHISTOCHEMISTRY; IRRITABLE COLON; MALE; MAST CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; REGULATORY MECHANISM; SCORING SYSTEM; STAINING; STATISTICAL SIGNIFICANCE;

ANIMALS; ELECTROACUPUNCTURE; IMMUNOHISTOCHEMISTRY; INDOLES; IRRITABLE BOWEL SYNDROME; MALE; MAST CELLS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE P; VASOACTIVE INTESTINAL PEPTIDE;

EID: 43049136639     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-007-0062-4     Document Type: Article

References (22)

1. Zouiten ML, Karoui S, Boubaker J, Fekih M, Mechmeche R, Filali A (2006) The pathophysiology of irritable bowel syndrome. Tunis Med 84:269-274
2. Farhadi A, Keshavarzian A, Van de Kar LD, Jakate S, Domm A, Zhang L, Shaikh M, Banan A, Fields JZ (2005) Heightened responses to stressors in patients with inflammatory bowel disease. Am J Gastroenterol 100:1796-1804
3. Yang YS, Zhou DY, Zhang WD, Zhang ZS, Song YG (1997) Mast cells of ileocecal junction in irritable bowel syndrome. Chin J Intern Med 36:231-233
4. Lewin I, Jacob-Hirsch J, Zang ZC, Kupershtein V, Szallasi Z, Rivera J, Razin E (1996) Aggregation of the Fc epsilon RI in mast cells induced the synthesis of Fos-interacting protein and increases its DNA binding activity: the dependence on protein kinase C-β. J Biol Chem 271:1514-1519
5. Metcalfe DD, Baram D, Mekori YA (1997) Mast cells. Physiol Rev 77:1033-1079
6. Ansel JC, Brown JR, Payan DG, Brown MA (1993) Substance P selectively activates TNF-alpha gene expression in murine mast cells. J Immunol 150:4478-4485
7. Tuncel N, Tore F, Sahinturk V, Ak D, Tuncel M (2000) Vasoactive intestinal peptide inhibits degranulation and changes granular content of mast cells: a potential therapeutic strategy in controlling septic shock. Peptides 21:81-89
8. Espejo EF, Gil E (1998) Antagonism of perpheral 5-HT4 receptors reduces visceral and cutaneous pain in mice, and induces visceral analgesia after simultaneous inactivation of 5-HT3 receptors. Brain Res 788:20-24
9. Kozlowski CM, Green A, Grundy D, Boissonade FM, Bountra C (2000) The 5-HT(3) receptor antagonist alosetron inhibits the colorectal distention induced depressor response and spinal c-fos expression in the anesthetised rat. Gut 46:474-480
10. AL-chaer ED, Kawasaki M, Pasricha PJ (2000) A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development. Gastroenterology 119:1276-1285
11. Williams CL, Villar RG, Peterson JM, Burks TF (1988) Stress-induced changes in intestinal transit in the rat: a model for irritable bowel syndrome. Gastroenterology 94:611-617
12. Tache Y, Perdue MH (2004) Role of peripheral CRF signalling pathays in stress-related alterations of gut motility and mucosal function. Neurogastroenterol Motil 16(Suppl 1):137
13. Yamamoto O, Niida H, Tajima K, Shirouchi Y, Kyotani Y, Ueda F, Kise M, Kimura K (1998) Effect of YNS-15 P: a new alpha-2 adrenoceptor antagonist on stress stimulated colonic propulsion in rats. J Pharmacol Exp Ther 287:691-696
14. Barbara G, De Giorgio R, Stanghellini V, Cremon C, Corinaldesi R (2002) A role for inflammation in irritable bowel syndrome? Gut 51:141-144
15. Gwee KA, Leong YL, Graham C, McKendrick MW, Collins SM, Walters SJ, Underwood JE, Read NW (1999) The role of psychological and biological factors in postinfective gut dysfunction. Gut 44:400-406
16. Tornblom H, Lindberg G, Nyberg B, Veress B (2002) Fullthickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology 123:1972-1979
17. Dong WZ, Zou DW, Li ZS, Xun GM, Zou XP, Zhu AY, Yin N, Man XH (2004) Study of visceral hypersensitivity in irritable bowel syndrome. Chin J Dig 24:18-22
18. O'Sullivan M, Clayton N, Breslin NP, Harman I, Bountra C, McLaren A, O'Morain CA (2000) Increased mast cells in the irritable bowel syndrome. Neurogastroenterol Motil 12:449-457
19. Bauer O, Razin E (2000) Mast cell-nerve interactions. News Physiol Sci 15:213-218
20. Zar S, Kumar D (2002) Role of food hypersensitivity in irritable bowel syndrome. Minerva Med 93:403-412
21. Gebhart GF (2000) Pathobiology of visceral pain: molecular mechanisms and therapeutic implications IV. Visceral afferent contributions to the pathobiology of visceral pain. Am J Physiol Gastrointest Liver Physiol 278:G834-G838
22. La JH, Kim TW, Sung TS, Kim HJ, Kim JY, Yang IS (2004) Role of mucosal mast cells in visceral hypersensitivity in a rat model of irritable bowel syndrome. J Vet Sci 5:319-324